Across Protocol vs Bio Protocol — how do they compare? Across Protocol trades at Rp744.7 (market cap Rp505,3M, Rp188,8M 24h volume), while Bio Protocol trades at Rp438.83 (market cap Rp1T, Rp164,61M 24h volume). The key difference: Bio Protocol is far larger — about 1979× Across Protocol 's market cap, and Across Protocol 's circulating supply is 716,5M / 1B ACX (72%) versus 2,3B / 3,3B BIO (69%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Across Protocol for 57 Days and Bio Protocol for 18 Days on average.
| ACX | BIO | |
|---|---|---|
Market Cap | Rp505,3M | Rp1T |
Volume (24h) | Rp188,8M | Rp164,61M |
Circulating Supply | 716,5M / 1B ACX (72%) | 2,3B / 3,3B BIO (69%) |
Typical Hold Time | 57 Days | 18 Days |
Signals from Pluang's Aura AI — not financial advice
Across Protocol (ACX) is trading at Rp728.43 with a market cap of Rp505.3M, showing bearish technical signals with 15 sell signals versus 3 buys. The token is near its pivot point of Rp714, with key support at Rp665 and resistance at Rp751. With 72% of max supply in circulation and average hold time of 57 days, the token shows moderate distribution. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in oversold RSI conditions suggesting potential bounce, while major risks include low liquidity and concentrated sell pressure. Investors should monitor support levels closely and watch for any protocol developments that could shift momentum.
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Across (ACX) is a cross-chain token bridge secured by UMA's optimistic oracle. Designed for capital efficiency, ACX features a single liquidity pool, competitive relayer options, and a no-slippage fee model. Because its oracle verifies transfers optimistically, ACX is able to process cross-chain transfers quickly.
Read more on ACX →BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →